Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Jan;11(1):9-19.
doi: 10.1177/1753465816676222. Epub 2016 Oct 27.

Endoscopic lung volume reduction coil treatment in patients with chronic hypercapnic respiratory failure: an observational study

Marcel Simon  1 , Lars Harbaum  1 , Tim Oqueka  1 , Stefan Kluge  2 , Hans Klose  3
Affiliations
Observational Study

Endoscopic lung volume reduction coil treatment in patients with chronic hypercapnic respiratory failure: an observational study

Marcel Simon et al. Ther Adv Respir Dis. 2017 Jan.

Abstract

Background: Endoscopic lung volume reduction coil (LVRC) treatment is an option for selected patients with severe emphysema. In the advanced stages, emphysema leads to respiratory failure: hypoxemia and eventually chronic hypercapnic respiratory failure. It can be hypothesized that LVRC treatment, a procedure targeting hyperinflation and thereby reducing ventilatory workload, may be especially beneficial in patients with chronic hypercapnic respiratory failure. This study was conducted to gain first insights into the effects and the safety of LVRC treatment in patients with emphysema and chronic hypercapnic respiratory failure.

Methods: A retrospective observational study conducted in the Department of Respiratory Medicine at the University Medical Center Hamburg-Eppendorf, Germany on all patients with chronic hypercapnic respiratory failure in whom bilateral LVRC treatment was performed between 1 April 2012 and 30 September 2015.

Results: During the study period, bilateral LVRC treatment was performed in 10 patients with chronic hypercapnic respiratory failure. Compared with baseline, bilateral LVRC treatment led to a significant increase in mean forced expiratory volume in one second (FEV1) from 0.5 ± 0.1 l to 0.6 ± 0.2 l ( p = 0.004), a decrease in residual volume (RV) from 6.1 ± 0.9 l to 5.6 ± 1.1 l ( p = 0.02) and a reduction in partial pressure of carbon dioxide in arterial blood (PaCO2) from 53 ± 5 mmHg to 48 ± 4 mmHg ( p = 0.03). One case of hemoptysis requiring readmission to hospital was the only severe adverse event.

Conclusions: LVRC treatment was safe and effective in patients with nonsevere chronic hypercapnic respiratory failure. It led not only to an improvement in lung function but also to a significant decrease in PaCO2.

Keywords: chronic hypercapnic respiratory failure; emphysema; endoscopic lung volume reduction; endoscopic lung volume reduction coil; interventional pulmonology.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MS and HK declare that they serve as advisors for PneumRx and have received honoraria for talks and workshops. None of the authors has any financial interest in the company.

Figures

Figure 1.
Figure 1.
Flow diagram illustrating the process of case selection. COPD, chronic obstructive pulmonary disease; LVRC, endoscopic lung volume reduction coil; PaCO2, partial pressure of carbon dioxide in arterial blood.
Figure 2.
Figure 2.
Changes in lung function. Lung function at baseline, after unilateral LVRC treatment and after bilateral LVRC treatment. FEV1, forced expired volume in one second; FVC, forced vital capacity; LVRC, endoscopic lung volume reduction coil; RV, residual volume.
Figure 3.
Figure 3.
Changes in exercise capacity. Showing 6-min walk distance at baseline, after unilateral LVRC treatment and after bilateral LVRC treatment. LVRC, endoscopic lung volume reduction coil; 6-MWT, 6-minute walk test.
Figure 4.
Figure 4.
Changes in PaCO2. PaCO2 at baseline, after unilateral LVRC treatment and after bilateral LVRC treatment. LVRC, endoscopic lung volume reduction coil; PaCO2, partial pressure of carbon dioxide in arterial blood.
See this image and copyright information in PMC

References

    1. Albert R., Benditt J., Hildebrandt J., Wood D., Hlastala M. (1998) Lung volume reduction surgery has variable effects on blood gases in patients with emphysema. Am J Respir Crit Care Med 158: 71–76. - PubMed
    1. Argenziano M., Moazami N., Thomashow B., Jellen P., Gorenstein L., Rose E., et al. (1996) Extended indications for lung volume reduction surgery in advanced emphysema. Ann Thorac Surg 62: 1588–1597. - PubMed
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111–117. - PubMed
    1. Bierach J., Maloney J., Ferguson J. (2013) Endobronchial valve placement for a giant bulla in a patient with hypercapnic respiratory failure. Ann Am Thorac Soc 10: 521–524. - PubMed
    1. Budweiser S., Heinemann F., Meyer K., Wild P., Pfeifer M. (2006) Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation. Respir Care 51: 126–132. - PubMed

Publication types

LinkOut - more resources